By patenting their innovations, our clients increase the value of their intellectual property and enhance their ability to compete in the marketplace. We work with individual scientists and engineers, laboratory and research teams, and R&D and product development groups to determine whether, when and where it is in our clients' business and technical interests to seek patent protection. And we don't just file patent applications. Drawing on our experience with patent litigation, corporate financings and technology transactions, we implement IP strategies that conserve resources, add measurable value and give our clients a cost-effective and commercially practical competitive edge.

Over the past two years, we filed nearly 4,000 US and foreign patent applications and obtained more than 1,700 US and foreign patents for our clients, covering innovations that span the technological spectrum, including aerospace, biochemistry, biotechnology, business methods, chemistry, computer science, fuel cells, genetics, high speed data communication, integrated circuits, materials science, medical devices, nanotechnology, pharmaceuticals, semiconductor devices/processes, and software. We also prepare and prosecute patent applications internationally—under the Patent Cooperative Treaty and in working with a network of seasoned patent lawyers around the world. Our experience extends to appeals, interferences and opposition proceedings within the USPTO, the US Court of Appeals for the Federal Circuit and the European Patent Office. 

Contacts

Sort By
Steinberg, Donald R.

Donald R. Steinberg

Chair, Intellectual Property Department

+1 617 526 6453 (t)

don.steinberg@wilmerhale.com

Haag, Joseph F.

Joseph F. Haag

Vice Chair, Intellectual Property Department

+1 650 858 6032 (t)

joseph.haag@wilmerhale.com

Experience

In recent matters, we:

  • Filed and obtained patents covering methods of treatment using NitroMed's commercial drug product, BiDil®—which is targeted to the treatment of heart failure in black patients—and worked with the company on the implementation of strategies for product life cycle management
  • Prosecuted a large and complex family of US and foreign patents for Wyeth and its licensee XCyte, concerning an anti-cancer immunotherapy that is currently in Phase III clinical trials
  • Represented Columbia University in the negotiation of several intellectual property licenses, and in patent prosecution relating to diverse fields such as software applications, integrated circuits, life sciences, chemistry and physical sciences

Publications & News

View

April 11, 2017

Patent Law and the Supreme Court: Patent Certiorari Petitions Denied in 2017

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently denied petitions, organized in reverse chronological order by date of certiorari petition.

April 11, 2017

Patent Law and the Supreme Court: Patent Certiorari Petitions Granted

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently granted petitions, organized in reverse chronological order by date of certiorari petition.

April 11, 2017

Patent Law and the Supreme Court: Patent Certiorari Petitions Pending

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all pending petitions, organized in reverse chronological order by date of certiorari petition.

April 3, 2017

Practice Tips for Patentees Asserting Method-of-Treatment Claims Involving Divided Infringement

In this article published by BNA's Patent, Trademark and Copyright Journal, Kevin Prussia, Jamie Wisz and Steven Horn detail tips for patentees asserting method-of-treatment claims involving divided infringement.

March 21, 2017

WilmerHale Recognized for Outstanding International Lawyers and Practices in Chambers Global 2017

Chambers Global has named 27 WilmerHale lawyers among "The World's Leading Lawyers for Business" in its 2017 edition.

December 30, 2016

Patent Law and the Supreme Court: Patent Certiorari Petitions Denied in 2016

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently denied petitions, organized in reverse chronological order by date of certiorari petition.

December 9, 2016

WilmerHale Listed Among Top Thought Leaders in Life Sciences Law Firm Index

Lake Whillans evaluated firms based on the strength of elements such as white papers, contributions to third-party media and speaking engagements.

November 9, 2016

LMG Life Sciences Ranks WilmerHale and Attorneys Among the Best

The 2016 supplement highlights nine firm practices and 18 attorneys, recognizing work under three categories—Intellectual Property, Finance and Transactional, and Non-IP Litigation and Enforcement.

November 4, 2016

WilmerHale Lawyers, Practice Recognized for Outstanding Work and Reputation by Chambers UK 2017

Chambers UK: A Client's Guide to the UK Legal Profession 2017 ranked five WilmerHale lawyers and one practice for outstanding work and reputation.

October 25, 2016

Design Patent Post-Grant: Is Anticipation Easier to Prove Than Obviousness?

An article by Ben Fernandez and Mark Selwyn, published by Bloomberg BNA's Patent Trademark & Copyright Journal, introduces and compares the standards for design patent anticipation and obviousness, explores the interplay between anticipation and obviousness at the PTAB, and summarizes practical takeaways from the current design patent IPR landscape.

Current Developments

Patent Certiorari Petitions

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently pending, granted and denied petitions, organized in each listing in reverse chronological order by date of certiorari petition.

Patent Law and the Supreme Court: Certiorari Petitions Pending

Patent Law and the Supreme Court: Certiorari Petitions Granted

Patent Law and the Supreme Court: Certiorari Petitions Denied

For more information on these petitions or other patent appeal matters, contact:

Joseph J. Mueller (+1 617 526 6396, joseph.mueller@wilmerhale.com)
Thomas G. Saunders (+1 202 663 6536, thomas.saunders@wilmerhale.com)
Leslie Pearlson (+1 617 526 6809, leslie.pearlson@wilmerhale.com)